Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is proud to announce its ...

旧金山——根据监管文件显示，Hims & Hers Health, Inc.（纽约证券交易所代码：HIMS）首席执行官Andrew Dudum最近出售了33,513股A类普通股。这些股票于2024年12月2日以平均每股33.38美元的价格售出，总计约112万美元。

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.

2024年12月3日，保健护理服务公司Hims & Hers Health（HIMS）成交额为4.51亿美元，在当日美股中排第171名，成交额较昨日减少9.36%，当日成交量为1384.68万。

旧金山——根据最近的SEC文件，Hims & Hers Health, Inc.（NYSE:HIMS）的首席商务官Michael Chi最近进行了一系列股票交易。12月2日，Chi以每股33.56美元的价格出售了2,054股A类普通股，总计68,932美元。

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s stock price gapped up prior to trading on Monday after Canaccord Genuity Group raised their price target on the stock from $28.00 to $38.00.

Canaccord raised the firm’s price target on Hims & Hers to $38 from $28 and keeps a Buy rating on the shares. The stock rallied 70% in ...

Finding the right treatment for erectile dysfunction (ED) can feel overwhelming with so many options out there! Rugiet, ...

While Hims offers more options for sexual health and hair loss, Roman offers more options overall. Here’s our full breakdown of Hims vs. Roman for erectile dysfunction, hair loss, and more.

On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $32.15 which represents a slight increase of $1.81 or 5.97% from the prior close of $30.34. The stock opened at ...